Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LIAISON VZV IgG HT, LIAISON Control VZV IgG HT

K-Number: K231214 · 2023-10-27

Decision Date2023-10-27
Product CodeLFY
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

LIAISON VZV IgG HT, LIAISON Control VZV IgG HT is a medical device manufactured by DiaSorin, Inc.. It received FDA 510(k) clearance on 2023-10-27 under approval number K231214. The device is classified under product code LFY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LIAISON VZV IgG HT, LIAISON Control VZV IgG HT?

LIAISON VZV IgG HT, LIAISON Control VZV IgG HT is a medical device that received FDA 510(k) clearance on 2023-10-27. It is manufactured by DiaSorin, Inc.. The 510(k) number is K231214.

When was LIAISON VZV IgG HT, LIAISON Control VZV IgG HT approved by the FDA?

LIAISON VZV IgG HT, LIAISON Control VZV IgG HT received FDA 510(k) clearance on 2023-10-27, under approval number K231214.

What company makes LIAISON VZV IgG HT, LIAISON Control VZV IgG HT?

LIAISON VZV IgG HT, LIAISON Control VZV IgG HT is manufactured by DiaSorin, Inc..

What is the FDA product code for LIAISON VZV IgG HT, LIAISON Control VZV IgG HT?

The FDA product code for LIAISON VZV IgG HT, LIAISON Control VZV IgG HT is LFY.

Other Devices by DiaSorin, Inc.

View all 41 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.